Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old [Phase 3]
Phase 3 trial evaluating adding Lomustine to chemotherapy and allogeneic transplantation in older adults with acute myeloid leukemia; the st…
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial evaluating T-cell depleted allogeneic stem cell transplantation for hematologic malignancies; study is completed with…
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients [Phase 2, Phase 3]
Phase 2/3 trial evaluating AZD1152 alone and with low-dose cytosine arabinoside in acute myeloid leukemia has completed with posted results …
-
CLINICAL_TRIALS research · 2014-03-26Clinical Trial Update: Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination [Phase 1, Phase 2]
Open-label Phase 1/2 clinical trial evaluating the safety and tolerability of donor-derived allogeneic B-cell concentrates to support immune…
-
CLINICAL_TRIALS trial_result · 2014-03-21Clinical Trial Update: Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant [Phase 1]
Phase 1 trial evaluating vaccine therapy with or without donor lymphocyte infusion in patients with acute myeloid leukemia, acute lymphoblas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia [Phase 2]
Phase II study of clofarabine in adults with refractory or relapsed acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML) [Phase 1]
This is a Phase 1 clinical trial of clofarabine in Japanese patients with acute myeloid leukemia. The study has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy [Phase 1]
A National Cancer Institute-sponsored Phase 1 trial evaluating sunitinib malate in HIV-positive cancer patients on antiretroviral therapy ha…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: A Safety and Tolerability Extension Trial Assessing Repeated Dosing of Anti-KIR (1-7F9) Human Monoclonal Antibody in Patients With Acute Myeloid Leukaemia [Phase 1]
This clinical-trial update describes a Phase 1 safety and tolerability extension study of repeated dosing with an anti-KIR monoclonal antibo…
-
CLINICAL_TRIALS research · 2014-02-27Clinical Trial Update: Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia [Phase 3]
A Phase 3 clinical trial evaluating a risk-factor–tailored therapy approach for adults ≤60 with acute myeloid leukemia. The document provide…
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia [Phase 2]
Phase 2 trial evaluating gemcitabine in children with relapsed or refractory acute lymphoblastic leukemia or acute myeloid leukemia has comp…
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy [Phase 2]
Phase 2 clinical trial evaluating gemtuzumab ozogamicin in young patients with newly diagnosed acute myeloid leukemia undergoing remission-i…
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating decitabine as maintenance therapy after standard treatment in adults with previously untreated acute myeloid leukem…
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes [Phase 1]
A Phase 1 trial in pediatric patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes evaluated a monoclonal…
-
CLINICAL_TRIALS withdrawal · 2014-02-11Clinical Trial Update: AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS [Phase 1, Phase 2]
A Phase 1/2 trial evaluating AMD3100 with busulfan, fludarabine, and thymoglobulin for allogeneic stem cell transplantation in acute myeloid…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial evaluating bortezomib in combination with chemotherapy for younger patients with recurrent, refractory, or secondary acute m…
-
CLINICAL_TRIALS trial_result · 2014-02-05Clinical Trial Update: Clofarabine in Adult Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for clofarabine in adult patients with advanced solid tumors and various hematologic conditions; the…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: PRO#0118: Decitabine Plus Mini Flu-Bu [Phase 1]
A Phase 1 trial evaluating decitabine with a mini Flu-Bu conditioning regimen for acute myeloid leukemia and myelodysplastic syndrome has co…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
A phase 1/2 trial evaluating the combination of clofarabine and cytarabine in children with refractory or relapsed acute myeloid leukemia or…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial update for elesclomol sodium in patients with relapsed or refractory acute myeloid leukemia, sponsored by Synta Pharm…
-
FDA approval · 2014-01-23FDA Approved: DECITABINE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' original application for decitabine. The drug is used to treat myelodysplastic syndromes and…
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 2]
A Phase 2 trial evaluating CLAG plus Gleevec (imatinib) in relapsed or refractory acute myeloid leukemia has completed, with results posted …
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Ondansetron Versus Aprepitant Plus Ondansetron for Emesis [Phase 2]
Phase 2 trial comparing ondansetron alone versus aprepitant plus ondansetron for prevention of emesis in patients with hematologic diseases,…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating the combination of arsenic trioxide, cytarabine, and idarubicin in patients with acute myeloid leukemia has compl…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial evaluating VNP40101M followed by cytarabine in older adults with acute myeloid leukemia.